>Introduction: The number of cardiovascular disease patients in my country is as high as 330 million, usually combined with metabolic risk factors, leading to an increased risk of cardiovascular events and death, posing a serious threat to national health. In order to further implement the standardized management goals of the “Healthy China Action” on hypertension, diabetes, and dyslipidemia, and improve the diagnosis rate, treatment rate and control rate of the “Three Highs”, Suzhou Industrial Park Cardiovascular Health Research Institute launched the “Three Highs Co-management Action”. ——New chronic disease management medical prevention collaborative promotion project”.
August 7, 2022, ” The kick-off meeting of the New Chronic Disease Management Medical Prevention Collaborative Promotion Project was successfully held. The meeting specially invited Mao Qun’an, Director of the Planning, Development and Informatization Department of the National Health Commission to attend the meeting for guidance, and invited Academician Ge Junbo of Zhongshan Hospital Affiliated to Fudan University, Professor Huo Yong of Peking University First Hospital, Professor Ji Linong of Peking University People’s Hospital, and Peking University People’s Hospital. Professor Sun Ningling of the Hospital, Professor Ye Ping of the First Medical Center of the PLA General Hospital, Professor Li Yong of Huashan Hospital Affiliated to Fudan University, Professor Huang Kai of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Professor Peng Yongde of the First People’s Hospital Affiliated to Shanghai Jiaotong University, Peking Union Medical College More than ten cardiovascular and endocrinology experts, including Professor Xiao Xinhua from the hospital and Professor Chen Lulu from the Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, participated in the meeting to explore new strategies for comprehensive prevention and control of chronic diseases in healthy China.
The three chairmen’s speeches kicked off the kick-off meeting. Academician Ge Junbo pointed out that the co-management of the three highs is an important strategic deployment for the construction of “Healthy China 2030”, which will help to comprehensively improve the level of cardiovascular disease prevention and control in my country. It can delay or even block the occurrence and development of cardiovascular and cerebrovascular diseases. Professor Huo Yong said that the “Healthy China Action (2019-2030)” proposed for the first time at the national level to promote the joint management of “three highs”, and to do a good job in the standardized management of hypertension, diabetes and dyslipidemia. Doing a good job in the comprehensive prevention and control of “three highs and joint management” can greatly improve the overall prevention and control efficiency of cardiovascular diseases. Professor Ji Linong proposed that clinicians should pay more attention to the cardio-renal outcomes of patients with diabetes, do a good job in risk assessment and stratified management of cardiovascular disease in diabetic patients, and use new hypoglycemic drugs with clear evidence of improving cardio-renal outcomes, which can effectively reduce diabetes. Risk of cardiovascular and cerebrovascular disease and renal disease in patients.
Department of Planning, Development and Informatization of the National Health and Health Commission
Director Mao Qun’an of the Department of Planning, Development and Informatization of the National Health and Health Commission conducted a “Three High, accelerate the realization of a healthy China” keynote speech, pointed out that the CPC Central Committee has always placed the protection of people’s health in the strategic position of priority development, and made the decision and deployment of “implementing a healthy China strategy”. With the joint efforts of various localities and departments, the concept of general health and general health has gradually taken root in the hearts of the people, the policy system for health promotion has been basically established, and the main goals of the Healthy China Action in 2022 have been achieved ahead of schedule. The “Three Highs Co-management Action” project launched today is an important attempt to protect key groups and prevent and control major diseases based on the main risk factors affecting patients with three highs. It is hoped that relevant departments, experts and all sectors of society will work together to explore ” “Three highs” jointly manage the road of high-quality development.
AstraZeneca China Mr. Lai Minglong, the manager, said in his speech that AstraZeneca has always been committed to the areas where patients need the most urgently, and will continue to promote interdisciplinary exchanges in the future, so as to realize the early realization of the three-high patients’ treatment.General management contributes modestly. Afterwards, all the guests attended the launching ceremony and took a group photo together, marking the official launch of the “Three-High Co-Management Action – New Chronic Disease Management Medical Prevention Collaborative Promotion Project”!
In the academic session of the conference, Professor Huang Kai first introduced the “Three-High Co-Management Action” project, and then Professor Ji Linong and Professor Li Yong respectively brought Excellent academic lectures. Professor Huang Kai
Tongji Medical College of China University of Science and Technology
Affiliated Union Hospital
Professor Huang Kai pointed out when introducing the “Three-High Co-Management Action Project Introduction and Implementation Plan” that the project plans to pass the “Three-High Co-Management Standardized Diagnosis and Treatment in China” Compilation of the Expert Consensus, popularize the combined screening of the three highs, strengthen the risk assessment of patients with the three highs and the multi-dimensional academic exchanges of the three highs co-management, improve the patient-centered comprehensive diagnosis and treatment of the three highs, and reduce the incidence and mortality of cardiovascular and metabolic diseases. Professor Ji LinongPeking University People’s Hospital
Professor Ji Linong pointed out in “Starting with the End – A New Concept of Cardiovascular Risk Assessment for Diabetes Patients” that the number of people with diabetes in my country is large, and the prevalence of other cardiovascular risk factors is severe. Patients bring a heavy burden of cardio-renal disease; early implementation of comprehensive and standardized management can effectively improve the cardio-renal outcomes of diabetic patients.
Professor Li Yong
Fudan University Affiliated Hospital /span>
Professor Li Yong emphasized in the “New Model of Comprehensive Management of Cardiometabolic Diseases” that cardiometabolic risk factors promote the development of cardiovascular events and cardiorenal syndrome Occurrence and development, and the concept of cardiometabolic diseases is constantly being updated, and foreign countries have gradually transformed from theory to clinical practice. The concept of “pan-vascular disease” proposed by Academician Ge Junbo provides new directions and ideas for the practice of cardiometabolic management in my country. Multidisciplinary comprehensive management of cardiometabolic diseases should be strengthened. On the basis of lifestyle improvement, early identification and screening of three highs Patients should be treated rationally according to risk stratification, and the long-term outcomes of patients with three high-levels should be improved through the clinical application of new hypoglycemic drugs such as SGLT2i.
The current situation of co-management of my country’s three highs, the core connotation of “three highs” comprehensive management, and the specific planning of projects were widely asked. Academician Ge Junbo, Professor Huo Yong, Professor Ji Linong, Professor Li Yong, Professor Huang Kai, and Professor Chen Lulu gave detailed answers one by one. . Experts at the meeting emphasized the need for early screening and identification of the three high risk factors, and comprehensive ASCVD risk stratification for patients; in terms of treatment goals, it is necessary to focus not only on the short-term goals of the three high management, but also on the improvement of long-term cardio-renal outcomes. Improve patient life expectancy and quality of life.
Finally, Prof. Chen Lulu summarized today’s meeting, emphasizing again the “three high-level joint management actions”. “The project actively responds to relevant national policies, which is of great significance for exploring the new model of “three highs and co-management”. With strong support, the “Three-High Co-Management Action” will definitely promote the process of my country’s three-high co-management, improve the prevention and control status of the three-high patients, and contribute to the early realization of the grand goal of Healthy China 2030!
☟ Click to read the original text , watch the live replay!